LANA

Lana Medical Co.

9587StocksTadawulHealthcare

Financials

Income Statement Balance Sheet Cash Flow Ratios

Annual Semi-annual

Annual (SAR)

	2025Dec 31, 2025	2024Dec 31, 2024	2023Dec 31, 2023	2022Dec 31, 2022	2021Dec 31, 2021
Operating Summary
Revenue	92.30M	84.09M	48.63M	40.80M	31.97M
Cost of Revenue	71.47M	59.19M	29.42M	21.93M	15.10M
Gross Profit	20.84M	24.90M	19.21M	18.87M	16.87M
SG&A	18.81M	15.30M	11.61M	9.04M	8.47M
Operating Expenses	14.89M	16.42M	19.58M	12.35M	9.55M
Operating Income	5.95M	8.48M	-0.37M	6.52M	7.32M
Interest Expense	-2.39M	-0.48M	-0.34M	-0.20M	-0.08M
Other Income/Expense	214.86K	254.04K	182.42K	293.54K	541.06K
Pretax Income	3.75M	13.62M	-0.52M	6.62M	7.79M
Income Tax	1.05M	1.16M	1.41M	1.13M	1.20M
Net Income	2.70M	12.46M	-1.93M	5.49M	6.59M
EBITDA	10.27M	11.18M	1.11M	7.54M	8.09M
EBIT	5.95M	8.48M	-0.37M	6.52M	7.32M
EPS (Basic)	0.05	0.23	-0.04	0.12	0.20
EPS (Diluted)	0.05	0.23	-0.04	0.12	0.20
DPS	0.03	—	—	—	—
Margins & Efficiency
Gross Margin %	+22.6%	+29.6%	+39.5%	+46.3%	+52.8%
EBITDA Margin %	+11.1%	+13.3%	+2.3%	+18.5%	+25.3%
Net Margin %	+2.9%	+14.8%	-4.0%	+13.5%	+20.6%
Revenue & Income
Revenue	92.30M	84.09M	48.63M	40.80M	31.97M
Revenue Growth (YoY)	+9.8%	+72.9%	+19.2%	+27.6%	—
Earnings From Equity Investments	-0.75M	5.37M	—	—	—
Gain (Loss) on Sale of Assets	728.26K	—	—	—	8.00K
Expenses & Provisions
Advertising Expenses	412.62K	345.27K	330.61K	188.56K	—
Cost of Revenue	71.47M	59.19M	29.42M	21.93M	15.10M
Selling, General & Admin	18.81M	15.30M	11.61M	9.04M	8.47M
Operating Expenses	14.89M	16.42M	19.58M	12.35M	9.55M
Interest Expense	-2.39M	-0.48M	-0.34M	-0.20M	-0.08M
Other Non Operating Income (Expenses)	214.86K	254.04K	182.42K	293.54K	541.06K
D&A For EBITDA	4.32M	2.70M	1.48M	1.01M	0.77M
Profitability & Returns
Gross Profit	20.84M	24.90M	19.21M	18.87M	16.87M
Gross Margin	+22.6%	+29.6%	+39.5%	+46.3%	+52.8%
EBIT	5.95M	8.48M	-0.37M	6.52M	7.32M
EBIT Margin	+6.4%	+10.1%	-0.8%	+16.0%	+22.9%
EBITDA	10.27M	11.18M	1.11M	7.54M	8.09M
EBITDA Margin	+11.1%	+13.3%	+2.3%	+18.5%	+25.3%
EBT Excluding Unusual Items	3.02M	13.62M	-0.52M	6.62M	7.78M
Pretax Income	3.75M	13.62M	-0.52M	6.62M	7.79M
Operating Income	5.95M	8.48M	-0.37M	6.52M	7.32M
Operating Margin	+6.4%	+10.1%	-0.8%	+16.0%	+22.9%
Profit Margin	+2.9%	+14.8%	-4.0%	+13.5%	+20.6%
Net Income	2.70M	12.46M	-1.93M	5.49M	6.59M
Net Income to Common	2.70M	12.46M	-1.93M	5.49M	6.59M
Net Income Growth	-78.4%	—	—	-16.7%	—
Income Tax Expense	1.05M	1.16M	1.41M	1.13M	1.20M
Effective Tax Rate	+28.1%	+8.5%	—	+17.0%	+15.4%
Per Share & Capital
EPS (Basic)	0.05	0.23	-0.04	0.12	0.20
EPS (Diluted)	0.05	0.23	-0.04	0.12	0.20
EPS Growth	-78.4%	—	—	-39.2%	—
Dividend Per Share	0.03	—	—	—	—
Shares Change (YoY)	—	0.18	0.01	0.37	—
Shares Outstanding (Basic)	54.00M	54.00M	45.62M	45.00M	32.82M
Shares Outstanding (Diluted)	54.00M	54.00M	45.62M	45.00M	32.82M
Free Cash Flow	-10.37M	-3.73M	-2.43M	0.50M	-12.17M
Free Cash Flow Margin	-11.2%	-4.4%	-5.0%	+1.2%	-38.1%
Free Cash Flow Per Share	-0.19	-0.07	-0.05	0.01	-0.37

Income Statement Balance Sheet Cash Flow Ratios

Annual Semi-annual

Annual (SAR)

	2025Dec 31, 2025	2024Dec 31, 2024	2023Dec 31, 2023	2022Dec 31, 2022	2021Dec 31, 2021
Operating Summary
Revenue	92.30M	84.09M	48.63M	40.80M	31.97M
Cost of Revenue	71.47M	59.19M	29.42M	21.93M	15.10M
Gross Profit	20.84M	24.90M	19.21M	18.87M	16.87M
SG&A	18.81M	15.30M	11.61M	9.04M	8.47M
Operating Expenses	14.89M	16.42M	19.58M	12.35M	9.55M
Operating Income	5.95M	8.48M	-0.37M	6.52M	7.32M
Interest Expense	-2.39M	-0.48M	-0.34M	-0.20M	-0.08M
Other Income/Expense	214.86K	254.04K	182.42K	293.54K	541.06K
Pretax Income	3.75M	13.62M	-0.52M	6.62M	7.79M
Income Tax	1.05M	1.16M	1.41M	1.13M	1.20M
Net Income	2.70M	12.46M	-1.93M	5.49M	6.59M
EBITDA	10.27M	11.18M	1.11M	7.54M	8.09M
EBIT	5.95M	8.48M	-0.37M	6.52M	7.32M
EPS (Basic)	0.05	0.23	-0.04	0.12	0.20
EPS (Diluted)	0.05	0.23	-0.04	0.12	0.20
DPS	0.03	—	—	—	—
Margins & Efficiency
Gross Margin %	+22.6%	+29.6%	+39.5%	+46.3%	+52.8%
EBITDA Margin %	+11.1%	+13.3%	+2.3%	+18.5%	+25.3%
Net Margin %	+2.9%	+14.8%	-4.0%	+13.5%	+20.6%
Revenue & Income
Revenue	92.30M	84.09M	48.63M	40.80M	31.97M
Revenue Growth (YoY)	+9.8%	+72.9%	+19.2%	+27.6%	—
Earnings From Equity Investments	-0.75M	5.37M	—	—	—
Gain (Loss) on Sale of Assets	728.26K	—	—	—	8.00K
Expenses & Provisions
Advertising Expenses	412.62K	345.27K	330.61K	188.56K	—
Cost of Revenue	71.47M	59.19M	29.42M	21.93M	15.10M
Selling, General & Admin	18.81M	15.30M	11.61M	9.04M	8.47M
Operating Expenses	14.89M	16.42M	19.58M	12.35M	9.55M
Interest Expense	-2.39M	-0.48M	-0.34M	-0.20M	-0.08M
Other Non Operating Income (Expenses)	214.86K	254.04K	182.42K	293.54K	541.06K
D&A For EBITDA	4.32M	2.70M	1.48M	1.01M	0.77M
Profitability & Returns
Gross Profit	20.84M	24.90M	19.21M	18.87M	16.87M
Gross Margin	+22.6%	+29.6%	+39.5%	+46.3%	+52.8%
EBIT	5.95M	8.48M	-0.37M	6.52M	7.32M
EBIT Margin	+6.4%	+10.1%	-0.8%	+16.0%	+22.9%
EBITDA	10.27M	11.18M	1.11M	7.54M	8.09M
EBITDA Margin	+11.1%	+13.3%	+2.3%	+18.5%	+25.3%
EBT Excluding Unusual Items	3.02M	13.62M	-0.52M	6.62M	7.78M
Pretax Income	3.75M	13.62M	-0.52M	6.62M	7.79M
Operating Income	5.95M	8.48M	-0.37M	6.52M	7.32M
Operating Margin	+6.4%	+10.1%	-0.8%	+16.0%	+22.9%
Profit Margin	+2.9%	+14.8%	-4.0%	+13.5%	+20.6%
Net Income	2.70M	12.46M	-1.93M	5.49M	6.59M
Net Income to Common	2.70M	12.46M	-1.93M	5.49M	6.59M
Net Income Growth	-78.4%	—	—	-16.7%	—
Income Tax Expense	1.05M	1.16M	1.41M	1.13M	1.20M
Effective Tax Rate	+28.1%	+8.5%	—	+17.0%	+15.4%
Per Share & Capital
EPS (Basic)	0.05	0.23	-0.04	0.12	0.20
EPS (Diluted)	0.05	0.23	-0.04	0.12	0.20
EPS Growth	-78.4%	—	—	-39.2%	—
Dividend Per Share	0.03	—	—	—	—
Shares Change (YoY)	—	0.18	0.01	0.37	—
Shares Outstanding (Basic)	54.00M	54.00M	45.62M	45.00M	32.82M
Shares Outstanding (Diluted)	54.00M	54.00M	45.62M	45.00M	32.82M
Free Cash Flow	-10.37M	-3.73M	-2.43M	0.50M	-12.17M
Free Cash Flow Margin	-11.2%	-4.4%	-5.0%	+1.2%	-38.1%
Free Cash Flow Per Share	-0.19	-0.07	-0.05	0.01	-0.37